| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 174 |
| 1 | INFLIXIMAB | 96 |
| 2 | SODIUM OXYBATE | 84 |
| 3 | DUPILUMAB | 71 |
| 4 | PREDNISONE | 71 |
| 5 | ETANERCEPT | 67 |
| 6 | METHOTREXATE SODIUM | 61 |
| 7 | METHOTREXATE | 60 |
| 8 | INFLIXIMAB-DYYB | 56 |
| 9 | IBUPROFEN | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOHPEN, DEXTROMETHORPHAN HBR, GUAIFENESIN PHENYLEPHRINE HCL | 1 | 0.2500 |
| 1 | ACETAMINOHPEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0303 |
| 2 | EFLORNITHINE HYDROCHLORIDE | 1 | 0.0238 |
| 3 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0172 |
| 4 | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE | 1 | 0.0167 |
| 5 | INFLIXIMAB-DYYB | 56 | 0.0163 |
| 6 | ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL | 2 | 0.0128 |
| 7 | L-PHENYLALANINE | 1 | 0.0127 |
| 8 | SARECYCLINE HYDROCHLORIDE | 2 | 0.0100 |
| 9 | L-TYROSINE | 1 | 0.0074 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 226 |
| 1 | Corticosteroid [EPC] | 121 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 99 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 71 |
| 4 | Progestin [EPC] | 62 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 59 |
| 6 | Estrogen [EPC] | 57 |
| 7 | Vitamin C [EPC] | 52 |
| 8 | Provitamin D2 Compound [EPC] | 45 |
| 9 | Benzodiazepine [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 6 | 0.0025 |
| 2 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 6 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 7 | Glucosylceramide Synthase Inhibitor [EPC] | 2 | 0.0007 |
| 8 | Sympathomimetic-like Agent [EPC] | 20 | 0.0006 |
| 9 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |